Skip to content
The Policy VaultThe Policy Vault

Tocilizumab subcutaneous — Cigna

All Other Conditions (including systemic juvenile idiopathic arthritis)

Initial criteria

  • Patient meets the standard Inflammatory Conditions – Tocilizumab Subcutaneous Prior Authorization Policy criteria.

Approval duration

1 year